You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DRUG TARGETING

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Crohn Disease, Ulcerative Colitis Trial (Adalimumab-680LT, Control)

Not yet recruiting
  • Crohn Disease
  • Ulcerative Colitis
  • (no location specified)
Oct 30, 2023

Substance Use Disorder, Cocaine Use Disorder Trial in New York (Methylphenidate, Memory reconsolidation, Placebo)

Recruiting
  • Substance Use Disorder
  • Cocaine Use Disorder
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jul 28, 2023

Therapeutic Drug Monitoring - Targeting IMproved Effectiveness

Not yet recruiting
  • Pneumonia
  • +2 more
  • No intervention
  • (no location specified)
Jul 25, 2023

Leiomyosarcoma, Liposarcoma Trial in New York (ATX-101)

Recruiting
  • Leiomyosarcoma
  • Liposarcoma
  • New York, New York
    Columbia University Irving Medical Center / NewYork-Presbyterian
Nov 23, 2022

Transcranial Magnetic Stimulation, Drug Resistant Epilepsy, Cerebellum Trial (transcranial magnetic stimulation)

Not yet recruiting
  • Transcranial Magnetic Stimulation
  • +2 more
  • transcranial magnetic stimulation
  • (no location specified)
Mar 29, 2023

Insomnia Trial in Ann Arbor (Cognitive Behavioral Therapy for insomnia (CBTi-CB-TM), Sleep Hygiene Education (SHE-TM))

Not yet recruiting
  • Insomnia
  • Cognitive Behavioral Therapy for insomnia (CBTi-CB-TM)
  • Sleep Hygiene Education (SHE-TM)
  • Ann Arbor, Michigan
    University of Michigan
Apr 3, 2023

Drug Refractory Epilepsy Trial in Xi'an (cTBS First, Pseudo-stimulation First)

Recruiting
  • Drug Refractory Epilepsy
  • cTBS First
  • Pseudo-stimulation First
  • Xi'an, Shaanxi, China
    Xijing Hospital
Nov 29, 2021

Tuberculosis Trial in Mozambique, South Africa, Tanzania (Sutezolid, N-acetyl cysteine, Pretomanid)

Not yet recruiting
  • Tuberculosis
  • Maputo, Mozambique
  • +3 more
Jan 13, 2023

Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria Trial in Bangkok (Case Management and Follow-up, Reactive focal mass

Recruiting
  • Plasmodium Falciparum Malaria
  • Plasmodium Vivax Malaria
  • Case Management and Follow-up
  • Reactive focal mass drug administration (rfMDA)
  • Bangkok, Thailand
    Division of Vector Born Diseases, Ministry of Health
Mar 22, 2022

Cancer, Cancer, Lung Trial in Fairfax (CPO301)

Recruiting
  • Cancer
  • Cancer, Lung
  • Fairfax, Virginia
    NEXT Virginia
Jul 10, 2023

Protein Kinase Inhibitors, Other Protocol Specified Criteria, Lung Tumors Trial in Guangzhou (JYP0322)

Recruiting
  • Protein Kinase Inhibitors
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Nov 9, 2023

Myocardial Infarction Type 2 Trial (Coronary computed tomography angiography, Invasive coronary angiography, Transthoracic

Not yet recruiting
  • Myocardial Infarction Type 2
  • Coronary computed tomography angiography
  • +7 more
  • (no location specified)
Jun 15, 2022

Breast Cancer, Gastric Cancer, Gastroesophageal-junction Cancer Trial in Australia (IKS014)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Concord, New South Wales, Australia
  • +4 more
May 30, 2023

Nebulizers and Vaporizers Trial in Uppsala (PreciseInhale, Seretide Evohaler forte)

Completed
  • Nebulizers and Vaporizers
  • PreciseInhale
  • Seretide Evohaler forte
  • Uppsala, Sweden
    Clinical Trial Consultants AB
Apr 1, 2022

NSCLC Trial in Tai'an (Ametinib combined with bevacizumab)

Recruiting
  • Non-small Cell Lung Cancer
  • Ametinib combined with bevacizumab
  • Tai'an, Shandong, China
    The Second Affiliated Hospital of Shandong First Medical Univers
Feb 22, 2023

Opioid Use Disorder Trial in Seattle (ED-LINC)

Recruiting
  • Opioid Use Disorder
  • ED-LINC
  • Seattle, Washington
    Harborview Medical Center
May 13, 2022

Breast Tumors Trial in Shenyang (Next-generation Site-specific human epidermal growth factor receptor 2 (HER2)-targeting

Recruiting
  • Breast Neoplasms
  • Next-generation Site-specific human epidermal growth factor receptor 2 (HER2)-targeting Antibody-drug Conjugate (ARX788)
  • Shenyang, Liaoning, China
    Shengjing Hospital affiliated to China Medical University
Jul 30, 2022

Breast Cancer Trial in Spain (U3 1402)

Recruiting
  • Breast Cancer
  • U3 1402
  • Badalona, Barcelona, Spain
  • +9 more
Apr 1, 2022

Solid Tumor, Adult Trial in Boston, Canton, Houston (HB0045 Drug Product)

Not yet recruiting
  • Solid Tumor, Adult
  • HB0045 Drug Product
  • Boston, Massachusetts
  • +2 more
Sep 20, 2023

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Biopsy
  • +3 more
  • (no location specified)
Jan 18, 2023

Solid Tumor, Adult Trial in Boston, Canton, Houston (HB0045 Drug Product)

Not yet recruiting
  • Solid Tumor, Adult
  • HB0045 Drug Product
  • Boston, Massachusetts
  • +2 more
Jul 5, 2023

Diffuse Large B Cell Lymphoma (DLBCL) Trial in Denver, Nashville (bbT369)

Recruiting
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • bbT369
  • Denver, Colorado
  • +1 more
Feb 10, 2022

Alcohol or Other Drugs Use Trial in New York (HealthCall+Motivational Interviewing, Motivational Interviewing)

Completed
Has Results
  • Alcohol or Other Drugs Use
  • HealthCall+Motivational Interviewing
  • Motivational Interviewing
  • New York, New York
    The New York State Psychiatric Institute
Aug 15, 2021

Hiv Trial in Nairobi, (ASA 81mg, Control Group, ASA 325mg)

Recruiting
  • Hiv
  • ASA 81mg
  • +2 more
  • Nairobi,, Kenya
    Kenyan Aids Control Project/University of Nairobi
Jan 10, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +3 more
  • Biopsy
  • +4 more
  • (no location specified)
Jan 4, 2023